Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood

Journal of Medical Screening

Volumn 9, Issue 3, 2002, Pages 99-103

  Castiglione, G ^a   Grazzini, G ^a   Miccinesi, G ^a   Rubeca, T ^a   Sani, C ^a   Turco, P ^a   Zappa, M ^a  

^a Istituto Scientifico della Regione Toscana   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; FEMALE; HUMAN; IMMUNOCHEMISTRY; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PREDICTION;

ADENOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; LATEX FIXATION TESTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THRESHOLD LIMIT VALUES;

EID: 0036400615     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.9.3.99     Document Type: Article

References (30)

1. Mandel JS, Bond JH, Church, TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71
2. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-8
3. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71
4. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:399-400
5. Selby JV, Friedman GD, Quesenberry CP, et al. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 1193;118:1-6
6. Wahrendorf J, Robra BP, Wiebelt H, et al. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 1993;2:221-7
7. Lazovich DA, Weiss NS, Stevens NG, et al. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen 1995;2:84-9
8. Saito H, Soma Y, Koeda J, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995;61:465-9
9. Zappa M, Castiglione G, Grazzini G, et al. Effect of faecal occult blood testing on colorectal cancer mortality. Results of a case-control study population-based in the district of Florence. Int J Cancer 1997;73:208-10
10. Faivre J, Tazi MA, El Mrini T, et al. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 1999;79:680-3
11. Bertario L, Russo A, Crosignani P, et al. Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study. Eur J Cancer 1999;35:973-7
12. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7
13. Advisory Committee on Cancer Prevention. Position paper. Recommendations on CRC screening in European Union. Eur J Cancer 2000;36:1473-78
14. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guideline and rationale. Gastroenterology 1997;112:594-642
15. Conferenza permanente per i rapporti tra lo Stato, le Regioni, e le Province Autonome di Trento e Bolzano. Accordo tra il Ministro della sanità e le regioni e province autonome di Trento e Bolzano sulle linee-guida concernenti la prevenzione, la diagnostica e l'assistenza in oncologia. Gazzetta Ufficiale della Repubblica Italiana 2001;100(suppl):52-7
16. Gnauck R. Screening for colon cancer in Germany. Tumori 1995;81(suppl):30-7
17. Saito H, Yoshida Y. Mass screening: Japanese perspective. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996:301-12
18. Garvican L. Planning for a possible national colorectal cancer screening programme. J Med Screen 1998;5:187-94
19. Petrelli N, Michalek AM, Freedman A, et al. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol 1994;3:27-36
20. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 1996;334:155-9
21. Saito H, Soma Y, Nakajma M, et al. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep 2000;7:815-19
22. Zappa M, Castiglione G, Paci E, et al. Measuring interval cancers in a population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001;92:151-4
23. Castiglione G, Zappa M, Grazzini G, et al. Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. J Med Screen 1997;4:142-6
24. Yamamoto Y, Hino M, Minami Y, et al. Quantitative assay for fecal hemoglobin using an occult blood autoimmunoanalyser (OC-Sensor). Journal of Clinical Laboratory Instruments and Reagents 1990;13:683-9
25. Takabayashi T, Yuki H, Furuya S, et al. Clinical usefulness of a fecal occult blood autoimmunoanalyser (OC-Sensor). Japanese Journal of Clinical Laboratory Automation (JJCLA) 1992;16:62-165
26. Castiglione G, Zappa M, Grazzini G, et al. Screening for colorectal CRC by faecal occult blood test: comparison of immunochemical tests. J Med Screen 2000;7:35-7
27. Itoh M, Takahashi K, Nishida H, et al. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen 1996;3:66-71
28. Grazzini G, Castiglione G, Isu A, et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori 2000;86:384-8
29. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994;271:1011-3
30. Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions. JNCI 1997;89:1423-8